Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $419000.0.

  • TriSalus Life Sciences' Other Non-Current Assets fell 117.92% to $419000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $419000.0, marking a year-over-year decrease of 117.92%. This contributed to the annual value of $423000.0 for FY2024, which is 922.75% down from last year.
  • Per TriSalus Life Sciences' latest filing, its Other Non-Current Assets stood at $419000.0 for Q3 2025, which was down 117.92% from $419000.0 recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Other Non-Current Assets peaked at $466000.0 during Q4 2023, and registered a low of $367000.0 during Q4 2022.
  • Moreover, its 4-year median value for Other Non-Current Assets was $423500.0 (2024), whereas its average is $415700.0.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first soared by 2697.55% in 2023, then crashed by 922.75% in 2024.
  • Over the past 4 years, TriSalus Life Sciences' Other Non-Current Assets (Quarter) stood at $367000.0 in 2022, then rose by 26.98% to $466000.0 in 2023, then fell by 9.23% to $423000.0 in 2024, then decreased by 0.95% to $419000.0 in 2025.
  • Its last three reported values are $419000.0 in Q3 2025, $419000.0 for Q2 2025, and $424000.0 during Q1 2025.